Beclorest Inhalation solution
PDF Leaflet Revision Date: 14 May 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylactic treatment of bronchospasm in asthma.
Dosage (summary)
Adults: 200 u03bcg twice daily, max 1000 u03bcg. Children: 50-100 u03bcg 2-4 times daily, max 500 u03bcg.
Special Populations
- Children
- Patients on systemic corticosteroids
Pregnancy & Breastfeeding
Safety in pregnancy not established; use with caution in breastfeeding.
Key Drug Interactions
- CYP3A inhibitors (e.g., ritonavir, cobicistat)
- Disulfiram
- Metronidazole
Contraindications
- Hypersensitivity to beclometasone
- Acute status asthmaticus
Common side effects
- Oral candidiasis
- Hoarseness
- Throat irritation
- Headache
Counselling Points
- Use regularly even when asymptomatic
- Rinse mouth after use
- Have relief medication available
Serious warnings
- Does not relieve acute asthma symptoms
- Risk of adrenal suppression
- Monitor growth in children
Important Disclaimer
The Beclorest Inhalation solution professional information leaflet below is the property of Ipharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
